Search

Subject Cancer Issue Volume 41:Issue 2(2023)

1. A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006). Issue 2 (7th September 2022)

Authors:
Tanyi, Janos L.; Randall, Leslie M.; Chambers, Setsuko K.; Butler, Kristina A.; Winer, Ira S.; Langstraat, Carrie L.; Han, Ernest S.; Vahrmeijer, Alexander L.; Chon, Hye Sook; Morgan, Mark A.; Powell, Matthew A.; Tseng, Jill H.; Lopez, Alexis S.; Wenham, Robert M.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
276
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Population-Based Study of the Long-Term Risk of Infections Associated With Hospitalization in Childhood Cancer Survivors. Issue 2 (25th July 2022)

Authors:
Chehab, Leena; Doody, David R.; Esbenshade, Adam J.; Guilcher, Gregory M.T.; Dvorak, Christopher C.; Fisher, Brian T.; Mueller, Beth A.; Chow, Eric J.; Rossoff, Jenna
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
364
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial. Issue 2 (22nd July 2022)

Authors:
Fornecker, Luc-Matthieu; Lazarovici, Julien; Aurer, Igor; Casasnovas, René-Olivier; Gac, Anne-Claire; Bonnet, Christophe; Bouabdallah, Krimo; Feugier, Pierre; Specht, Lena; Molina, Lysiane; Touati, Mohamed; Borel, Cécile; Stamatoullas, Aspasia; Nicolas-Virelizier, Emmanuelle; Pascal, Laurent; Lug...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
327
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134. Issue 2 (27th September 2022)

Authors:
Atkins, Michael B.; Lee, Sandra J.; Chmielowski, Bartosz; Tarhini, Ahmad A.; Cohen, Gary I.; Truong, Thach-Giao; Moon, Helen H.; Davar, Diwakar; O'Rourke, Mark; Stephenson, Joseph J.; Curti, Brendan D.; Urba, Walter J.; Brell, Joanna M.; Funchain, Pauline; Kendra, Kari L.; Ikeguchi, Alexandra P.;...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. Issue 2 (12th October 2022)

Authors:
Lindgren, Maria S.; Hansen, Erik; Azawi, Nessn; Nielsen, Anna M.; Dyrskjøt, Lars; Jensen, Jørgen B.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
206
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search